{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:03:30Z","timestamp":1787731410508,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.bone.2019.01.004","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T02:28:57Z","timestamp":1546568937000},"page":"68-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Serum periostin levels and severity of fibrous dysplasia of bone"],"prefix":"10.1016","volume":"121","author":[{"given":"H.","family":"Guerin Lemaire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Merle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Borel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gensburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Chapurlat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.bone.2019.01.004_bb0005","doi-asserted-by":"crossref","first-page":"P120","DOI":"10.1359\/jbmr.06s223","article-title":"G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome","volume":"21","author":"Weinstein","year":"2006","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2019.01.004_bb0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1096-9896(199901)187:2<249::AID-PATH222>3.0.CO;2-J","article-title":"The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks","volume":"187","author":"Riminucci","year":"1999","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.bone.2019.01.004_bb0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.berh.2007.11.004","article-title":"Fibrous dysplasia of bone and McCune\u2013Albright syndrome","volume":"22","author":"Chapurlat","year":"2008","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.bone.2019.01.004_bb0020","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/jbmr.2894","article-title":"Prognostic factors from an epidemiologic evaluation of fibrous dysplasia of bone in a modern cohort: the FRANCEDYS study","volume":"31","author":"Benhamou","year":"2016","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2019.01.004_bb0025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1359\/JBMR.0301262","article-title":"Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome","volume":"19","author":"Leet","year":"2004","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2019.01.004_bb0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bone.2004.03.004","article-title":"Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment","volume":"35","author":"Chapurlat","year":"2004","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2019.01.004_bb0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1359\/JBMR.041111","article-title":"An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone","volume":"20","author":"Collins","year":"2005","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.01.004_bb0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mce.2015.12.014","article-title":"Periostin action in bone","volume":"432","author":"Bonnet","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"issue":"7","key":"10.1016\/j.bone.2019.01.004_bb0045","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00018-013-1494-y","article-title":"The role of periostin in tissue remodeling across health and disease","volume":"71","author":"Conway","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.bone.2019.01.004_bb0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.humpath.2008.07.008","article-title":"Periostin, a novel marker of intramembranous ossification, is expressed in fibrous dysplasia and in c-Fos-overexpressing bone lesions","volume":"40","author":"Kashima","year":"2009","journal-title":"Hum. Pathol."},{"issue":"7","key":"10.1016\/j.bone.2019.01.004_bb0055","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1210\/jc.2013-3893","article-title":"Serum periostin is associated with fracture risk in postmenopausal women: a 7-year prospective analysis of the OFELY study","volume":"99","author":"Rousseau","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.bone.2019.01.004_bb0060","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.joca.2015.05.015","article-title":"Serum periostin is associated with prevalent knee osteoarthritis and disease incidence\/progression in women: the OFELY study","volume":"23","author":"Rousseau","year":"2015","journal-title":"Osteoarthr. Cartil."},{"issue":"6","key":"10.1016\/j.bone.2019.01.004_bb0065","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/jbmr.3105","article-title":"Bone microarchitecture assessed by HR-pQCT as predictor of fracture risk in postmenopausal women: the OFELY study","volume":"32","author":"Sornay-Rendu","year":"2017","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2019.01.004_bb0070","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00198-014-2974-0","article-title":"Family resemblance of bone turnover rate in mothers and daughters\u2014the MODAM study","volume":"26","author":"Nagy","year":"2015","journal-title":"Osteoporos. Int."},{"issue":"8","key":"10.1016\/j.bone.2019.01.004_bb0075","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/jbmr.3451","article-title":"Prediction of fractures in men using bone microarchitectural parameters assessed by high-resolution peripheral quantitative computed tomography-the prospective STRAMBO study","volume":"33","author":"Szulc","year":"2018","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2019.01.004_bb0080","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bjd.12117","article-title":"Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis","volume":"168","author":"Yamaguchi","year":"2013","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.bone.2019.01.004_bb0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/ACI.0000000000000426","article-title":"Biomarkers and asthma management: analysis and potential applications","volume":"18","author":"Richards","year":"2018","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.bone.2019.01.004_bb0090","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s00198-017-4034-z","article-title":"Circulating periostin levels increase in association with bone density loss and healing progression during the early phase of hip fracture in Chinese older women","volume":"28","author":"Yan","year":"2017","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.bone.2019.01.004_bb0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00223-010-9391-y","article-title":"Development of a new ELISA for serum periostin: evaluation of growth-related changes and bisphosphonate treatment in mice","volume":"87","author":"Conti\u00e9","year":"2010","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.bone.2019.01.004_bb0100","first-page":"145","article-title":"Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment","volume":"46","author":"Anastasilakis","year":"2014","journal-title":"Horm. Metab. Res."},{"issue":"7","key":"10.1016\/j.bone.2019.01.004_bb0105","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/jbmr.3136","article-title":"Cathepsin K controls cortical bone formation by degrading periostin","volume":"32","author":"Bonnet","year":"2017","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2019.01.004_bb0110","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1359\/jbmr.080609","article-title":"Age-dependent demise of GNAS-mutated skeletal stem cells and \u201cnormalization\u201d of fibrous dysplasia of bone","volume":"23","author":"Kuznetsov","year":"2008","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2019.01.004_bb0115","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1210\/jc.2017-00283","article-title":"The effect of teriparatide treatment on circulating periostin and its relationship to regulators of bone formation and BMD in postmenopausal women with osteoporosis","volume":"103","author":"Gossiel","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2019.01.004_bb0120","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/iep.12171","article-title":"High-level expression of periostin is significantly correlated with tumour angiogenesis and poor prognosis in osteosarcoma","volume":"97","author":"Hu","year":"2016","journal-title":"Int. J. Exp. Pathol."},{"issue":"10","key":"10.1016\/j.bone.2019.01.004_bb0125","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.1038\/bcj.2016.90","article-title":"High levels of periostin correlate with increased fracture rate, diffuse MRI pattern, abnormal bone remodeling and advanced disease stage in patients with newly diagnosed symptomatic multiple myeloma","volume":"6","author":"Terpos","year":"2016","journal-title":"Blood Cancer J."},{"issue":"10","key":"10.1016\/j.bone.2019.01.004_bb0130","doi-asserted-by":"crossref","first-page":"e46670","DOI":"10.1371\/journal.pone.0046670","article-title":"Cancer stem cell-related gene periostin: a novel prognostic marker for breast cancer","volume":"7","author":"Xu","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bone.2019.01.004_bb0135","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00223-018-0444-y","article-title":"The C-terminal intact forms of periostin (iPTN) are surrogate markers for osteolytic lesions in experimental breast cancer bone metastasis","volume":"105","author":"Gineyts","year":"2018","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.bone.2019.01.004_bb0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00198-007-0425-x","article-title":"Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions","volume":"19","author":"Kelly","year":"2008","journal-title":"Osteoporos. Int."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2019.01.004_bb0145","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1750-1172-7-S1-S3","article-title":"Pathophysiology and medical treatment of pain in fibrous dysplasia of bone","volume":"7","author":"Chapurlat","year":"2012","journal-title":"Orphanet. J. Rare Dis."},{"issue":"10","key":"10.1016\/j.bone.2019.01.004_bb0150","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/rheumatology\/kev410","article-title":"Novel biological markers of bone: from bone metabolism to bone physiology","volume":"55","author":"Chapurlat","year":"2016","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.bone.2019.01.004_bb0155","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jbmr.1546","article-title":"Mechanism of FGF23 processing in fibrous dysplasia","volume":"27","author":"Bhattacharyya","year":"2012","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2019.01.004_bb0160","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J. Clin. Invest."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219300043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219300043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T08:57:12Z","timestamp":1573635432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328219300043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":32,"alternative-id":["S8756328219300043"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2019.01.004","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum periostin levels and severity of fibrous dysplasia of bone","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2019.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}